Valicenti Advisory Services Inc. Lowers Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Valicenti Advisory Services Inc. lowered its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 6.9% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 15,680 shares of the financial services provider’s stock after selling 1,165 shares during the period. Valicenti Advisory Services Inc.’s holdings in iShares Biotechnology ETF were worth $2,283,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. Blue Fin Capital Inc. raised its position in iShares Biotechnology ETF by 0.7% in the 2nd quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock worth $1,443,000 after purchasing an additional 74 shares during the period. Security National Bank of SO Dak raised its position in iShares Biotechnology ETF by 0.7% in the 2nd quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock worth $1,436,000 after purchasing an additional 75 shares during the period. SPC Financial Inc. raised its position in iShares Biotechnology ETF by 2.4% in the 3rd quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after purchasing an additional 75 shares during the period. Werba Rubin Papier Wealth Management raised its position in iShares Biotechnology ETF by 2.7% in the 3rd quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock worth $425,000 after purchasing an additional 76 shares during the period. Finally, Main Street Financial Solutions LLC raised its position in iShares Biotechnology ETF by 1.0% in the 2nd quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock worth $1,098,000 after purchasing an additional 82 shares during the period. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.4 %

Shares of NASDAQ:IBB opened at $141.59 on Friday. The company’s fifty day moving average is $145.62 and its 200 day moving average is $139.93. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were given a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.